institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Case Builds for Biogen, Stoke's Dravet Syndrome Drug

Summary by Pharmaphorum
Hopes have risen for a new treatment for severe childhood epilepsy Dravet syndrome, on the back of new data for Biogen and Stoke's zorevunersen

2 Articles

One in every 20,000 newborns can develop Dravet syndrome, also known as severe myoclonic epilepsy in childhood, a rare and severe form of epilepsy that usually manifests during the first year of life. Children with this disorder face frequent and prolonged seizures, as well as major difficulties in neurodevelopment. In addition, they often have cognitive and motor impairment, such as learning delays, difficulties in communicating, feeding, and o…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Newsweek México broke the news in on Thursday, July 10, 2025.
Sources are mostly out of (0)